11p11.2 (Potocki-Shaffer syndrome) region (includes ALX4, EXT2)
  • 3
    Haplo
    Score
  • 0
    Triplo
    Score

Region Facts

Region Name
11p11.2 (Potocki-Shaffer syndrome) region (includes ALX4, EXT2)
Cytoband
11p11.2
Genomic Coordinates
GRCh37/hg19 chr11:43894800-46152450 NCBI Ensembl UCSC
GRCh38/hg38 chr11:43873250-46130899 NCBI Ensembl UCSC

Dosage Sensitivity Summary (Region)

Dosage ID:
ISCA-37441
Curation Status:
Complete
Issue Type:
Dosage Curation - Region
Description:
Potocki-Shaffer syndrome DELETION INFO: ISCA P Value: ND EICHLER P Value: 0.1199 OMIM: #601224 SEG DUP mediated: No REFS: Reference 1: Wakui, et al., Europ J Hum Genet. 13:528-540, 2005; PMID: 15852040; Reference 2: Watkins, et al., Nature Genet. 11:434-437, 1995; PMID: 7493025; Reference 3: Hershberger, et al., GeneReviews. URL: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=dcm-ov accessed on 05/07/2009
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Read full report...
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Read full report...
Related Links:
Last Evaluated:
12/12/2013

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
HI Evidence:
  • PUBMED: 15852040
    Wakui et al. (2005) compare deletion size and phenotype in 10 individuals affected with Potocki-Shaffer syndrome (PSS). Full spectrum of PSS is seen in individuals with deletions at least 2.1 Mb (chr11:43894800-46152450 [hg19]), including both ALX4 and EXT2. ALX4 haploinsufficiency results in parietal foramina and EXT2 haploinsufficiency results in exostoses.
  • PUBMED: 16319823
    Mavrogiannis et al. (2006) describe mutations in homeobox genes ALX4 and MSX2 causing craniosynostosis. In this study, they identified a three-generation family with a deletion on chr11:40406581-44924293 [hg19], which includes the ALX4 and EXT2 genes manifesting enlarged parietal foramina and exostoses of the long bones. This family did not have intellectual disability, and by STR and FISH mapping the deletion of this family against other reported deletions in the literature, the authors propose that the gene(s) involved in this phenotype are proximal to EXT2 in PSS subjects.
  • PUBMED: 20140962
    Swarr et al. (2010) provide a comprehensive clinical description of PSS based on meta analysis of 6 individuals with cytogenetically defined 11p deletions and review of the literature. While the deletions were of various sizes and linear positions, all included ALX4 and EXT2, accounting for the cardinal features of craniofacial anomalies, enlarged parietal foramina, and exostoses of the long bones. The authors also make evaluation and maintenance recommendations for PSS individuals based on the primary clinical findings.
HI Evidence Comments:
Potocki-Shaffer syndrome (PSS) is a contiguous gene deletion syndrome with clinical features including developmental delay, mental retardation, multiple exostoses, parietal foramina, enlarged anterior fontanel, minor craniofacial anomalies, ophthalmologic anomalies, and genital abnormalities in males. Though a definitive critical region for this syndrome has not been determined, the coordinates used here are those proposed by Wakui et al (2005) (PMID:15852040): chr11:43894800-46152450 (hg19).

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)

Genomic View

Select assembly: (NC_000011.9) ()